(IN BRIEF) Boehringer Ingelheim has entered into a multi-year collaboration with Cue Biopharma to develop and commercialize CUE-501, a first-in-class bispecific compound designed to selectively deplete harmful B cells in autoimmune diseases. The innovative therapy uses Cue’s Immuno-STAT™ platform to … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged autoimmune diseases, B cell depletion, biologics innovation, biopharma collaboration, bispecific compound, Boehringer Ingelheim, Carine Boustany, chronic disease treatment, Cue Biopharma, CUE-501, Daniel Passeri, drug development, Immuno-STAT, Immuno-STAT platform, immunology pipeline, inflammatory diseases, licensing agreement, memory T cells, milestone payments, partnership, precision medicine, royalty payments, strategic partnership, T cell engagers, targeted biologics, up-front payment
(IN BRIEF) A University of Liverpool spin-out company, Ocuwell Ltd, is leading an ambitious UK-South Korea collaboration to advance personalised treatment for common corneal conditions like myopia and astigmatism, which affect over 30% of the global population. Supported by £1.4 … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Ahmed Elsheikh, AI in medicine, astigmatism, cataract surgery, collagen cross-linking, corneal biomechanics, Daniela Oehring, EYEREUM Clinic, in vivo characterisation, intracorneal ring segments, keratoconus, KHIDI, myopia, numerical modelling, ocular healthcare, Ocuwell Ltd, orthokeratology, partnership, personalised eye care, precision medicine, refractive errors, UK-South Korea Digital Health CRD, UKRI, University of Liverpool, University of Plymouth, University of Ulsan, Yonsei University
(IN BRIEF) The Bavarian High-Tech Awards were presented for the first time by the Bavarian State Government and the Bavarian Academy of Sciences and Humanities to recognize emerging talents and distinguished researchers. Among the awards, the High-Tech Young Investigator Award, … Read the full press release
Posted in Artificial Intelligence (AI), Awards, Business, Education, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged 000 euros, 30, AI in Women's Health, Awards, Bavarian Academy of Sciences and Humanities, Bavarian High-Tech Awards, Bavarian State Government, BRCA1, BRCA2, Dr. Jacqueline Lammert, Dr. Markus Söder, Hercules Hall, High-Tech Graduate Award, High-Tech Young Investigator Award, Hightech Agenda Bayern, INNOVATION, large language models, leadership, Munich Residence, oncology, precision medicine, RESEARCH, Science Minister Markus Blume, technology investments, TUM University Hospital
(IN BRIEF) A collaborative study led by Bayer and Hurdle, in partnership with top academic institutions including the University of Birmingham and the University of Edinburgh, has introduced and validated InflammAge—a novel, non-invasive saliva-based biomarker that quantifies systemic chronic inflammation, … Read the full press release
Posted in Business, Education, European Union, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged aging, Bayer, Cancer, cardiovascular disease, chronic inflammation, CRP, Dr. Daniel Martin-Herranz, Generation Scotland, Hurdle, InflammAge, lifestyle factors, neurodegenerative disorders, non-invasive testing, partnership, precision medicine, Professor Janet M Lord, Professor Riccardo E. Marioni, remote health monitoring, saliva-based DNA methylation biomarker, University of Birmingham, University of Edinburgh, Veronika Óvári
(IN BRIEF) The FORESIGHT consortium, comprising leading researchers from UMC Groningen, Amsterdam UMC, NKI/AVL, and TU/e, has launched a pioneering initiative to advance immunotherapy drug development by leveraging molecular imaging and AI technologies. With a grant of at least €9 … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Amsterdam UMC, autoimmune, cardiovascular, clinical studies, Fons van der Sommen, FORESIGHT consortium, Guus van Dongen, Health~Holland, imaging biomarkers, immunotherapy drug development, John Haanen, Liesbeth de Vries, Life Sciences & Health, molecular imaging, neurodegenerative, NKI/AVL, nuclear imaging, oncological, optical imaging, personalized medicine, Peter de With, precision medicine, preclinical studies, Public Private Partnership, Roy van der Meel, TU/e, UMC Groningen, Willem Mulder, €18 million funding, €9 million grant
(IN BRIEF) Researchers from the University of Copenhagen and Rigshospitalet have made significant strides in developing a new treatment for pancreatic cancer using antibody-drug conjugates (ADCs). This targeted therapy promises to improve survival rates by precisely attacking cancer cells while … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged ADC, antibody-drug conjugates, cancer treatment, chemotherapy, colon cancer, Finsen Laboratory, human clinical trials, immune system, Lars Henning Engelholm, pancreatic cancer, pharmaceutical research, precision medicine, Rigshospitalet, sarcoma, Science Advances, survival rates, targeted therapy, triple-negative breast cancer, University of Copenhagen
(PRESS RELEASE) PARIS AND MONTPELLIER, 30-Mar-2022 — /EuropaWire/ — ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health). This newly formed European public-private partnership aims at advancing precision … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, European Union, France, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged Alcediag, Alcen, Alexandra Prieux, artificial-intelligence, biomarkers, bipolar, bipolar disorder, blood test, Capital Region of Denmark, depression, diagnostics, EDIT-B Consortium, EIT health, Fundació Clinic per la Recerca Biomèdica, Fundació Sant Joan de Déu, GHU Paris Psychiatrie & Neurosciences, Hospital Clínic de Barcelona, IVD, Jean Marc Bourez, Maurizio Ferrari, mental health, neuropsychiatry, Parc Sanitari Sant Joan de Déu, precision medicine, precision psychiatry, ProductLife Group, Prof. Eduard Vieta, psychiatric disorders, Psychiatry, RNA editing, Synlab, World Bipolar Day
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?